Overview


According to FutureWise analysis the market for Over-the-Counter Pain Medication is expected to reach US$ 31.45 billion by 2031 at a CAGR of 4.30%.

OTC drugs are medicine that is sold to the public without the need to be prescribed by a healthcare professional. OTC drugs are usually selected by a regulatory agency to ensure they have safe and effective ingredients when being used without the supervision of a medical. OTC drugs usually have their active medicinal ingredient (API), regulated rather than the final products. The government regulates APIs and not specific drug formulations. This gives manufacturers the freedom to mix ingredients and combine them into proprietary mixtures. OTC means that a medicine can be purchased over the counter without a prescription. Prescription drugs, on the other hand, require a prescription from a doctor. Some drugs may be legally considered over-the-counter (i.e. There is no need for a prescription, but the drug may only be prescribed by a pharmacist after the assessment of the patient and the provision of education. The general rule is that OTC drugs can only be used to treat a condition without the supervision of doctors and must be proven to be safe and well-tolerated. OTC drugs usually have to have minimal or no abuse potential. However, in some areas, drugs like codeine can be purchased OTC (sometimes in very limited formulations or with identification required). Market regulations include prescription patterns, pharmaceutical and biologics rules, and disease epidemiology according to macro and industrial standards. The development of top-of-the-line pain relief products is one of the key developments in the market.

BPS values have dropped due to side effects from pain relievers. Consumer preference has shifted towards herbal and traditional therapies. Market growth has been further slowed due to the increased availability of prescription medications that include non-opioid and pain relief devices. The risk of multiple chronic pain diseases is high in an aging population. In addition, the growing number of elderly people around the world will likely increase the demand to buy over-the-counter pain medication. Demand for over-the-counter arthritis medication is expected to rise due to increasing pain from arthritis. The majority of OTC pain medication providers target this age group. OTC painkillers can have adverse effects that could be very undesirable. Heavy acetaminophen use can cause adverse side effects, including high blood pressure, heart disease, and increased risk for stroke.OTC pain medication must be used in moderation. If this is not done, it could have severe consequences on your health.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Over-the-Counter Pain Medication Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Over-the-Counter Pain Medication Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Sanofi S.A.
  • GlaxoSmithKline plc.
  • Bristo-Meyers Squibb and Company
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Merck & Co.
  • Cardinal Health Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Class

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anaesthetics
  • Acetaminophen

By Route of Administration

  • Oral Over-the-Counter Pain Medication
  • Topical Over-the-Counter Pain Medication
  • Others

By Dosage Form

  • Tablets
  • Capsules
  • Creams
  • Gels
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Over-the-Counter Pain Medication Market By Drug Class, By Route of Administration, By Dosage Form and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Over-the-Counter Pain Medication Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Over-the-Counter Pain Medication Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Over-the-Counter Pain Medication Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Over-the-Counter Pain Medication Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Local Anaesthetics
        3. Acetaminophen

  • 8.   Over-the-Counter Pain Medication Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral Over-the-Counter Pain Medication
        2. Topical Over-the-Counter Pain Medication
        3. Others

  • 9.   Over-the-Counter Pain Medication Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Tablets
        2. Capsules
        3. Creams
        4. Gels
        5. Others

  • 10.   North America Over-the-Counter Pain Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Over-the-Counter Pain Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Over-the-Counter Pain Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Over-the-Counter Pain Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Over-the-Counter Pain Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson & Johnson Services Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bayer AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sanofi S.A.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GlaxoSmithKline plc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bristo-Meyers Squibb and Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Teva Pharmaceutical Industries Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Mylan N.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Merck & Co.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cardinal Health Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients